Insulin Resistance: the Link Between Obesity and Cardiovascular Disease

Endocrinology and Metabolism Clinics of North America

Volumn 37, Issue 3, 2008, Pages 581-601

  Reaven, Gerald M ^a  

^a STANFORD UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

GLUCOSE; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; LOW DENSITY LIPOPROTEIN CHOLESTEROL;

ABDOMINAL FAT; BODY MASS; CARDIOVASCULAR DISEASE; CARDIOVASCULAR RISK; DISEASE ASSOCIATION; FITNESS; GLUCOSE HOMEOSTASIS; GLUCOSE TRANSPORT; GLYCEMIC CONTROL; HUMAN; INSULIN RESISTANCE; LIPOPROTEIN BLOOD LEVEL; MORBIDITY; MORTALITY; OBESITY; ORAL GLUCOSE TOLERANCE TEST; PHYSICAL ACTIVITY; PRIORITY JOURNAL; REVIEW; RISK ASSESSMENT; RISK FACTOR; RISK REDUCTION; WAIST CIRCUMFERENCE; WEIGHT REDUCTION;

ADIPOSITY; ANIMALS; BODY MASS INDEX; CARDIOVASCULAR DISEASES; CHOLESTEROL, HDL; GLUCOSE; HUMANS; INSULIN; INSULIN RESISTANCE; OBESITY; WAIST-HIP RATIO; WEIGHT LOSS;

EID: 50449100487     PISSN: 08898529     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ecl.2008.06.005     Document Type: Review

References (78)

1. Flegal K.M., Carroll M.D., Ogden C.L., et al. Prevalence and trends in obesity among US adults, 1999-2000. JAMA 288 (2002) 1723-1727
2. Hedley A.A., Ogden C.L., Johnson C.L., et al. Prevalence of overweight and obesity among US children, adolescents, and adults, 1999-2002. JAMA 291 (2004) 2847-2850
3. Allison D.B., Fontaine K.R., Manson J.E., et al. Annual deaths attributable to obesity in the United States. JAMA 282 (1999) 1530-1538
4. Fontaine K.R., Redden D.T., Wang C., et al. Years of life lost due to obesity. JAMA 289 (2003) 187-193
5. Hu F.B., Willett W.C., Li T., et al. Adiposity as compared with physical activity in predicting mortality among women. N Engl J Med 351 (2004) 2964-703
6. Calle E.E., Thun M.J., Petrelli J.M., et al. Body-mass index and mortality in a prospective cohort of US adults. N Engl J Med 341 (1999) 1097-1105
7. Yan L.L., Daviglus M.L., Liu K., et al. Midlife body mass index and hospitalization and mortality in older age. JAMA 295 (2006) 190-198
8. West K.M., and Kalbfleisch J.M. Influence of nutritional factors on prevalence of diabetes. Diabetes 20 (1971) 99-108
9. Havlik R.J., Hubert H.B., Fabsitz R.R., et al. Weight and hypertension. Ann Intern Med 98 (1983) 855-859
10. Wilson P.W., D'Agostino R.B., Sullivan L., et al. Overweight and obesity as determinants of cardiovascular risk: the Framingham experience. Arch Intern Med 162 (2002) 1867-1872
11. Manson J.E., Skerrett P.J., Greenland P., et al. The escalating pandemics of obesity and sedentary lifestyle. Arch Intern Med 164 (2004) 249-258
12. Flegal K.M., Graubard B.I., Williamson D.F., et al. Excess deaths associated with underweight, overweight, and obesity. JAMA 293 (2005) 1861-1867
13. Gregg E.W., Cheng Y.J., Cadwell B.L., et al. Secular trends in cardiovascular disease risk factors according to body mass index in US adults. JAMA 293 (2005) 1868-1874
14. Rosenthal M., Haskell W.L., Solomon R., et al. Demonstration of a relationship between level of physical training and insulin-stimulated glucose utilization in normal humans. Diabetes 32 (1983) 408-411
15. Bogardus C., Lillioja S., Mott D., et al. Relationship between obesity and maximal-insulin stimulated glucose uptake in vivo and in vitro in Pima Indians. J Clin Invest 73 (1984) 800-805
16. Bogardus C., Lillioja S., Mott D.M., et al. Relationship between degree of obesity and in vivo insulin action in man. Am J Physiol 248 (1985) E286-E291
17. Soman V.R., Koivisto V.A., Deibert D., et al. Increased insulin sensitivity and insulin binding to monocytes after physical training. N Engl J Med 301 (1978) 1200-1204
18. Koivisto V.A., Yki-Jarvinen H., and DeFronzo R.A. Physical training and insulin sensitivity. Diabetes Metab Rev (1986) 445-481
19. Goodyear L.J., and Kahn B.B. Exercise, glucose transport, and insulin sensitivity. Annu Rev Med 49 (1998) 235-261
20. Wessel T.R., Arant C.B., Olson M.B., et al. Relationship of physical fitness vs body mass index with coronary artery disease and cardiovascular events in women. JAMA 292 (2004) 1179-1187
21. Weinstein A.R., Sesso H.D., Lee I.M., et al. Relationship of physical activity vs body mass index with type 2 diabetes in women. JAMA 292 (2004) 1188-1194
22. Li T.Y., Rana J.S., Manson J.E., et al. Obesity as compared with physical activity in predicting risk of coronary heart disease in women. Circulation 31 (2006) 499-506
23. Sullivan P.W., Morrato E.H., Ghushchyan V., et al. Obesity, inactivity, and the prevalence of diabetes and diabetes-related cardiovascular comorbidities in the U.S., 2000-2002. Diabetes Care 28 (2005) 1599-1603
24. Rana J.S., Li T.Y., Manson J.E., et al. Adiposity compared with physical inactivity and risk of type 2 diabetes in women. Diabetes Care 30 (2007) 53-58
25. Olefsky J.M., Reaven G.M., and Farquhar J.W. Effects of weight reduction on obesity: studies of carbohydrate and lipid metabolism. J Clin Invest 53 (1974) 64-76
26. Ruderman N.B., Schneider S.H., and Berchtold P. The "metabolically-obese," normal weight individual. Am J Clin Nutr (1981) 1617-1621
27. Ferrannini E., Natali A., Bell P., et al. Insulin resistance and hypersecretion in obesity. J Clin Invest 100 (1997) 1166-1173
28. Executive summary of the third report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III). JAMA 285 (2002) 2486-2497
29. Alberti K.G., Zimmet P., Shaw J., and for the IDF Epidemiology Task Force Consensus Group. The metastatic syndrome-a new worldwide definition. Lancet 366 (2004) 1059-1061
30. Ford E.S., Mokdad A.H., and Giles W.H. Trends in waist circumference among U.S. adults. Obes Res 11 (2003) 1223-1231
31. Pei D., Jones C.N., Bhargava R., et al. Evaluation of octreotide to assess insulin-mediated glucose disposal by the insulin suppression test. Diabetologia 37 (1994) 843-845
32. Shen S.-W., Reaven G.M., and Farquhar J.W. Comparison of impedance to insulin mediated glucose uptake in normal and diabetic subjects. J Clin Invest 49 (1970) 2151-2160
33. Greenfield M.S., Doberne L., Kraemer F.B., et al. Assessment of insulin resistance with the insulin suppression test and the euglycemic clamp. Diabetes 30 (1981) 387-392
34. Farin H.M., Abbasi F., and Reaven G.M. Body mass index and waist circumference both contribute to differences in insulin-mediated glucose disposal in nondiabetic adults. Am J Clin Nutr 83 (2006) 47-51
35. Abate N., Garg A., Peshock R.M., et al. Relationships of generalized and regional adiposity to insulin sensitivity in man. J Clin Invest 96 (1995) 88-98
36. Cefalu W.T., Wang Z.Q., Werbgel S., et al. Contribution of visceral fat to the insulin resistance of aging. Metabolism 44 (1995) 954-959
37. Macor C., Ruggeri A., Mazzonetto P., et al. Visceral adipose tissue impairs insulin secretion and sensitivity, but not energy expenditure in obesity. Metabolism 46 (1997) 123-129
38. Goodpaster B.H., Thaete J.A., Simoneau J.A., et al. Subcutaneous abdominal fat and thigh muscle composition predict insulin sensitivity independently of visceral fat. Diabetes 46 (1997) 1579-1585
39. Banerji M.A., Faridi N., Atluri R., et al. Body composition, visceral fat, leptin and insulin resistance in Asian Indian men. J Clin Endocrinol Metab 84 (1999) 137-144
40. Kelley D.E., Thaete F.L., Troost F., et al. Subdivisions of subcutaneous abdominal tissue and insulin resistance. Am J Physiol Endocrinol Metab 278 (2000) E941-E948
41. Sites C.K., Calles-Escandon J., Brochu M., et al. Relation of regional fat distribution to insulin sensitivity in postmenopausal women. Fertil Steril 73 (2000) 61-65
42. Brochu M., Starling R.D., Tchernof A., et al. Visceral adipose tissue is an independent correlate of glucose disposal in older postmenopausal women. J Clin Endocrinol Metab 85 (2001) 2378-2384
43. Goran M.I., Bergman R.N., and Gower B.A. Influence of total vs. visceral fat on insulin action and secretion in African American and white children. Obes Res (2001) 423-431
44. Rendell M., Hulthen U.L., Tornquist C., et al. Relationship between abdominal fat compartments and glucose and lipid metabolism in early postmenopausal women. J Clin Endocrinol Metab 86 (2001) 744-749
45. Purnell J.Q., Kahn S.E., Schwartz R.S., et al. Relationship of insulin sensitivity and apoB levels to intra-abdominal fat in subjects with combined hyperlipidemia. Arterioscler Thromb Vasc Biol 21 (2001) 567-572
46. Raji A., Seeley E.W., Arky R.A., et al. Body fat distribution and insulin resistance in healthy Asian Indians and Caucasians. J Clin Endocrinol Metab 86 (2001) 5366-5371
47. Ross R., Aru J., Freman J., et al. Abdominal obesity and insulin resistance in obese men. Am J Physiol Endocrinol Metab 282 (2002) E657-E663
48. Ross R., Freeman J., Hudson R., et al. Abdominal obesity, muscle composition and insulin resistant in premenopausal women. J Clin Endocrinol Metab 87 (2002) 5044-5051
49. Cnop M., Landchild M.J., Vidal J., et al. The concurrent accumulation of intra-abdominal and subcutaneous fat explains the association between insulin resistance and plasma leptin concentrations. Diabetes 51 (2002) 1005-1015
50. Cruz M.L., Bergman R.N., and Goran M.I. Unique effect of visceral fat on insulin sensitivity in obese Hispanic children with a family history of type 2 diabetes. Diabetes Care 25 (2002) 1631-1636
51. Gan S.K., Krikeos A.D., Poynten A.M., et al. Insulin action, regional fat, and myocyte lipid; altered relationships with increased adiposity. Obes Res 11 (2003) 1295-1305
52. Tulloch-Reid M.K., Hanson R.L., Sebring N.G., et al. Both subcutaneous and visceral adipose tissues correlate highly with insulin resistance in African Americans. Obes Res (2004) 1352-1359
53. Rattarasarn C., Leelawattan R., Soonthornpun S., et al. Gender differences of regional abdominal fat distribution and their relationships with insulin sensitivity in healthy and glucose-intolerant Thais. J Clin Endocrinol Metab 89 (2004) 6266-6270
54. Raji A., Gerhard-Herman M.D., Warren M., et al. Insulin resistance and vascular dysfunction in nondiabetic Asian Indians. J Clin Endocrinol Metab 89 (2004) 3965-3972
55. Bush N.C., Darnell B.E., Oster R.A., et al. Adiponectin is lower among African Americans and is independently related to insulin sensitivity in children and adolescents. Diabetes 54 (2005) 2772-2778
56. Janssen I., Heymsfield S.B., Allison D.B., et al. Body mass index and waist circumference independently contribute to the prediction of nonabdominal, abdominal, subcutaneous, and visceral fat. Am J Clin Nutr 75 (2002) 683-688
57. Reaven G.M. Role of insulin resistance in human disease. Diabetes 37 (1988) 1595-1607
58. Reaven G.M. The insulin resistance syndrome. Curr Atheroscler Rep 5 (2003) 364-371
59. McLaughlin T., Abbasi F., Carantoni M., et al. Differences in insulin resistance do not predict weight loss in response to hypocaloric diets in healthy obese women. J Clin Endocrinol Metab 84 (1999) 578-581
60. Jones C.N., Abbas F., Carantoni M., et al. Roles of insulin resistance and obesity in regulation of plasma insulin concentrations. Am J Physiol Endocrinol Metab 278 (2000) E501-E508
61. McLaughlin T., Abbasi F., Kim H.-S., et al. Relationship between insulin resistance, weight loss, and coronary heart disease risk in healthy, obese women. Metabolism 50 (2001) 795-800
62. McLaughlin T., Abbasi F., Lamendola C., et al. Differentiation between obesity and insulin resistance in the association with C-reactive protein. Circulation 106 (2002) 2908-2912
63. McLaughlin T., Abbasi F., Cheal K., et al. Use of metabolic markers to identify overweight individuals who are insulin resistant. Ann Intern Med 139 (2003) 802-809
64. McLaughlin T., Abbasi F., Lamendola C., et al. Heterogeneity in the prevalence of risk factors for cardiovascular disease and type 2 diabetes in obese individuals: effect of differences in insulin sensitivity. Arch Intern Med 167 (2007) 642-648
65. McLaughlin T., Stuhlinger M., Lamendola C., et al. Plasma asymmetric dimethylarginine concentrations are elevated in obese insulin resistant women and fall with weight loss. J Clin Endocrinol Metab 91 (2006) 1896-1900
66. Genuth S., Alberti K.G., Bennett P., et al. Follow-up report on the diagnosis of diabetes mellitus. Diabetes Care 26 (2003) 3160-3167
67. Yeni-Komshian H., Carantoni M., Abbasi F., et al. Relationship between several surrogate estimates of insulin resistance and quantification of insulin-mediated glucose disposal in 490 healthy, nondiabetic volunteers. Diabetes Care 23 (2000) 171-175
68. Yip J., Facchini F.S., and Reaven G.M. Resistance to insulin-mediated glucose disposal as a predictor of cardiovascular disease. J Clin Endocrinol Metab 83 (1998) 2773-2776
69. Facchini F.S., Hua N., Abbasi F., et al. Insulin resistance as a predictor of age- related diseases. J Clin Endocrinol Metab 86 (2001) 3574-3578
70. Abbasi F., and Reaven G.M. Evaluation of the quantitative insulin sensitivity check index as an estimate of insulin sensitivity in humans. Metabolism 51 (2002) 235-237
71. Kim S.H., Abbasi F., and Reaven G.M. Impact of degree of obesity on surrogate estimates of insulin resistance. Diabetes Care 27 (2004) 1998-2002
72. McLaughlin T., Reaven G., Abbasi F., et al. Is there a simple way to identify insulin-resistant individuals at increased risk of cardiovascular disease?. Am J Cardiol 96 (2005) 399-404
73. Miller G.J., and Miller N.E. Plasma high-density-lipoprotein concentration and development of ischaemic heart disease. Lancet 1 (1975) 16-19
74. Carlson L.A., Bottiger L.E., and Ahfeldt P.E. Risk factors for myocardial infarction in the Stockholm prospective study: a 14-year follow-up focusing on the role of plasma triglycerides and cholesterol. Acta Med Scand 206 (1979) 351-360
75. Castelli W.P., Garrison R.J., Wilson P.W., et al. Incidence of coronary heart disease and lipoprotein cholesterol levels: the Framingham Study. JAMA 256 (1986) 2385-2387
76. Hokanson J.E., and Austin M.A. Plasma triglyceride level in a risk factor for cardiovascular disease independent of high-density lipoprotein cholesterol level: a meta-analysis of population-based prospective studies. J Cardiovasc Risk 3 (1996) 213-219
77. Galuska D.A., Will J.C., Serdula M.K., et al. Are health care professionals advising obese patients to lose weight?. JAMA 282 (1999) 1576-1578
78. Zavaroni I., Bonini L., Gasparini P., et al. Hyperinsulinemia in a normal population as a predictor of non-insulin-dependent diabetes mellitus, hypertension, and coronary heart disease: the Barilla factory revisited. Metabolism 48 (1999) 989-994